[HTML][HTML] Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes
RB Griggs, RR Donahue, BG Adkins, KL Anderson… - The Journal of …, 2016 - Elsevier
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
[HTML][HTML] Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes
RB Griggs, RR Donahue, BG Adkins… - The journal of pain …, 2016 - ncbi.nlm.nih.gov
Thiazolidinedione drugs (TZDs) such as pioglitazone are FDA-approved for the treatment of
insulin resistance in type 2 diabetes. However, whether TZDs reduce painful diabetic …
insulin resistance in type 2 diabetes. However, whether TZDs reduce painful diabetic …
Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes
RB Griggs, RR Donahue, BG Adkins, BK Taylor… - The Journal of …, 2016 - elibrary.ru
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
RB Griggs, RR Donahue, BG Adkins, KL Anderson… - The Journal of …, 2016 - infona.pl
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
[HTML][HTML] Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
RB Griggs, RR Donahue, BG Adkins, KL Anderson… - The Journal of …, 2016 - jpain.org
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
[引用][C] Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
RB Griggs, RR Donahue, BG Adkins, KL Anderson… - The Journal of …, 2016 - cir.nii.ac.jp
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal
Nociresponsive Neurons in Type 2 Diabetes | CiNii Research CiNii 国立情報学研究所 学術情報 …
Nociresponsive Neurons in Type 2 Diabetes | CiNii Research CiNii 国立情報学研究所 学術情報 …
Pioglitazone inhibits the development of hyperalgesia and sensitization of spinal nociresponsive neurons in type 2 diabetes
RB Griggs, RR Donahue, BG Adkins… - Journal of …, 2016 - experts.umn.edu
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
RB Griggs, RR Donahue, BG Adkins… - The journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes
RB Griggs, RR Donahue, BG Adkins… - The Journal of …, 2016 - hero.epa.gov
Thiazolidinedione drugs (TZDs) such as pioglitazone are approved by the US Food and
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Drug Administration for the treatment of insulin resistance in type 2 diabetes. However …
Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.
RB Griggs, RR Donahue, BG Adkins… - The Journal of …, 2015 - europepmc.org
Thiazolidinedione drugs (TZDs) such as pioglitazone are FDA-approved for the treatment of
insulin resistance in type 2 diabetes. However, whether TZDs reduce painful diabetic …
insulin resistance in type 2 diabetes. However, whether TZDs reduce painful diabetic …